Market Analysis - Monthly Report - June, 2020 - Erythromycin

Factory Name

Quotation (USD/KG)

Change (from last week)

Plant capacity

HEC

100

Stable

500MT/Year

QIYUAN

/

Stable

300MT/Year

TAIYICIN

105

Stable

300MT/Year

Influential Factors

Overview

Price Trend

Factory operating rate, inventory and cargo situation

In July, the factory operating rate will be the same as in June. The manufacturer will have no backlog of orders and have a small amount of inventory. QIYUAN will still be discontinued.

Decline

Market Demand

The international market demand will not change much. It is expected that the international market will rely more on China.

Stable

Market Sentiment

Customers will not make inventory. Only when there is real demand, it will be purchased.

Stable

Factory determination to raise prices

Domestic factories will maintain high prices, because India's production capacity will be affected by the price and supply of upstream raw materials.

Stable

Upstream raw materials

The upstream raw material Erythromycin thiocyanate is in short supply. Prices are high and stable.

Stable

Industry event

/

/

In conclusion

In July 2020, The market's supply and demand will not change much. Domestic factories will continue to maintain high prices. The upstream raw material erythromycin thiocyanate was tightly delivered, and the price was at a high level, which may rise. Therefore, in July, the price of erythromycin remained stable or rose slowly.

Stable